Fox News correspondent Grady Trimble has the latest on fears the technology will spiral out of control on'Special Report.' As the world of artificial intelligence blooms, some players in the health care industry are looking to make a major difference in public health. HMNC Brain Health -- a Munich, Germany-based health tech company -- is one of those. It's attempting to use novel AI-powered technologies to address mental health issues. The company has developed what's described as a "precision psychiatry" diagnostic tool that uses artificial intelligence to predict, diagnose and even treat depression.

The AAMA Silicon Valley & Silicon Valley Bank are excited to invite you to join The AAMA Digital Healthcare Connect Conference, an innovative half-day event on how healthcare technologies are being disrupted globally. Healthcare & LifeSciences are projected to be multi-$Billion industries in 2030. In fact, the Global Life Science Tools Market is projected to be $259B in 2030 alone! As a fellow industry executive/entrepreneur, come join us & meet the Disruptive Innovators in LifeSciences & Digital Health such as: - Dr. David Rhew, MD, Global Chief Marketing Officer, Microsoft - Dr. Kyu Rhee, MD, Chief Marketing Officer, CVS/Aetna - Jennifer Friel-Goldstein, Managing Partner, Life Sciences & Healthcare, SVB Capital - Leaders from Amazon/Alexa, HealthQuest Capital ($1.5B fund); Stanford Medical Center; American Heart Association & more! Attendees to our AAMA Global Healthcare Conference will learn about Leading Edge Insights in Digital Health, Life Sciences, Investments & Breakthrough Career Opportunities for Now & the Future.

Iterative Scopes, a pioneer in precision-medicine technologies for gastroenterology, announced that Shrujal Baxi, MD, MPH, has joined its leadership team as Chief Medical Officer. "Having a stellar scientific, medical, and regulatory affairs team is critical to Iterative Scopes' work, and we're very excited to have Dr. Baxi leading these groups," says Jonathan Ng, MBBS, founder and CEO of Iterative Scopes. "As a medical oncologist, Dr. Baxi has witnessed a transformation in oncology that has accelerated the public's understanding of cancer while also fueling precise management of the disease. Data has driven this innovation and knowledge generation, and I look forward to seeing her apply this expertise to our focus on individualized care for people with inflammatory bowel disease." Dr. Baxi specializes in real-world evidence generation, and throughout her career has been involved in multiple clinical trials.

Ontrak, Inc. (NASDAQ: OTRK) ("Ontrak Health" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today promoted Judith Feld, MD, to Chief Medical Officer replacing Robert Accordino, MD, who is leaving Ontrak Health to focus on his private practice. Dr. Feld begins immediately in the role and will report to Brandon LaVerne, Co-President and Chief Operating Officer. Dr. Feld joined Ontrak in 2019 as National Medical Director and was promoted to Chief Clinical Strategy Officer earlier this year. She has been instrumental in developing Ontrak Health's new evidence-based clinical model that engages hard to reach members on behalf of health plans through a whole-person approach to care and treatment. Dr. Feld brings over 30 years of experience to the role and is a Distinguished Life Fellow of the American Psychiatric Association, from whom she received the APA's Bruno Lima Award for Disaster Relief for her volunteer work in New Orleans with first responders following Hurricane Katrina.

What have I learned that might be helpful in preparing aspiring computer scientists to lead impactful and meaningful professional lives?

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced that Harry Kovelman, MD, is joining the Company as its Chief Medical Officer, effective November 2. In this role, Dr. Kovelman will oversee Myomo's patient advocacy organization, which helps ensure MyoPro patients' clinical qualification for the brace and pursues insurance coverage. At Myomo, he will work closely with commercial and government payer organizations to continue to increase patient access to the MyoPro product line. Dr. Kovelman brings 25 years of experience in medical devices and pharmaceuticals, including roles as Global Medical Director for Orthopedics at Ottobock Healthcare and Global Medical Affairs Director for Dynasplint Systems. He has also held senior executive roles at Pacira Pharmaceuticals, and Helius Medical Technologies. He is the author of several papers on rehabilitation procedures and has presented at numerous professional conferences on various innovations in healthcare products and services.

Robert Wachter, a former member of Google's healthcare advisory board, remembers when the company first set its sights on the healthcare industry more than a decade ago. "They said: We're Google, we'll solve it," says Wachter, head of medicine at University of California, San Francisco. At the time, Google was trying to create individual accounts where users could store their electronic medical records. So when then-chief executive Eric Schmidt later abandoned the effort with an admission that Google had underestimated the challenge, it came as a shock. "They conquer industry after industry, it doesn't seem like this would be very different," Wachter says.

As pressures on healthcare systems intensify, an increasing number of consumers are turning to the use of symptom checkers in the search for fast answers – or guidance – to any concerns that they may have. But although these tools have become popular, questions around their accuracy, and not only, are plaguing the digital health space. Last week, at Slush, Ada Health cofounder and chief medical officer Claire Novorol spoke to Wired UK's Victoria Turk about the Berlin-headquartered company's approach to building trust in its AI-powered chatbot. "Absolutely key, first of all, is the quality of the product," Novorol told the audience. "So what we've always focused on from the very beginning, eight years ago now actually, is the quality of the core product, the foundation of everything that we do, and that's our knowledge base, our reasoning engine, and how it works, the clinical quality of that, accuracy, safety."

Utilizing, and expanding upon, available technology in medical practices can efficiently improve healthcare, said Bobby Green, MD, chief medical officer at Flatiron. Utilizing, and expanding upon, available technology in medical practices can efficiently improve healthcare, said Bobby Green, MD, chief medical officer at Flatiron. Transcript How is Flatiron working to expand beyond the EHR to optimize clinical workflow? So, 1 of the areas that I think is really exciting and where there's been a lot of early work at flatiron--we've started to see some direct applications--is around artificial intelligence and machine learning. These are things that are in some ways sort of buzzwords in our field.

Britain's chief medical officer has been instructed by health secretary Matt Hancock to draw up official guidelines on time limits for social media use. Mr Hancock said he was "very worried" as a father by growing evidence of the detrimental effect social media was having on the health of young people. So he said he had instructed Dame Sally Davies to prepare official guidance on safe time limits, which would work in a similar way to safe alcohol limits. Facebook mistake leaves 50 million people's accounts exposed Instagram founders resign from social media giant after eight years What are the benefits of giving up social media? Facebook mistake leaves 50 million people's accounts exposed What are the benefits of giving up social media?